| Lifestyle interventions for the prevention of Parkinson disease: a recipe for action JM Janssen Daalen, S Schootemeijer, E Richard, SKL Darweesh, ... Neurology 99 (7 Supplement 1), 42-51, 2022 | 33 | 2022 |
| Determinants of drug prices: a systematic review of comparison studies JM Janssen Daalen, A den Ambtman, M Van Houdenhoven, ... BMJ Open 11 (7), e046917, 2021 | 23 | 2021 |
| Prodromal cognitive deficits and the risk of subsequent Parkinson’s disease DHB Speelberg, JM Janssen Daalen, BR Bloem, JF Gagnon, B Post, ... Brain Sciences 12 (2), 199, 2022 | 9 | 2022 |
| Towards subgroup-specific risk estimates: A meta-analysis of longitudinal studies on olfactory dysfunction and risk of Parkinson’s disease JM Janssen Daalen, A Tosserams, P Mahlknecht, K Seppi, BR Bloem, ... Parkinsonism & Related Disorders, 2021 | 9 | 2021 |
| Multiple N-of-1 trials to investigate hypoxia therapy in Parkinson’s disease: study rationale and protocol JM Janssen Daalen, MJ Meinders, F Giardina, KCB Roes, ... BMC Neurology 22 (1), 1-12, 2022 | 7 | 2022 |
| The Hypoxia Response Pathway: A Potential Intervention Target in Parkinson's Disease? JM Janssen Daalen, WJH Koopman, CGJ Saris, MJ Meinders, ... Movement Disorders 39 (2), 273-293, 2024 | 2 | 2024 |
| Reply to: Hypoxia treatment of Parkinson’s disease may disrupt the circadian system JM Janssen Daalen, MJ Meinders, IR Straatsma, PN Ainslie, ... BMC neurology 23 (1), 235, 2023 | 1 | 2023 |
| Case management interventions in chronic disease reduce anxiety and depressive symptoms: a systematic review and meta-analysis AD Geerlings, JM Janssen Daalen, JHL Ypinga, BR Bloem, MJ Meinders, ... Plos one 18 (4), e0282590, 2023 | 1 | 2023 |
| How vacations affect Parkinson’s disease JM Janssen Daalen, J Hubbers, M Sharifi Bonab, S Mathur, DHJ Thijssen, ... Movement Disorders Clinical Practice, 2022 | 1* | 2022 |
| Randomized controlled trial of intermittent hypoxia in Parkinson’s disease: study rationale and protocol JM Janssen Daalen, MJ Meinders, S Mathur, HWH van Hees, PN Ainslie, ... BMC Neurology 24 (1), 1-10, 2024 | | 2024 |
| Digital biomarkers for non-motor symptoms in Parkinson’s disease: the state of the art JM Janssen Daalen, R van den Bergh, EM Prins, MSC Moghadam, ... npj Digital Medicine 7 (1), 186, 2024 | | 2024 |
| How Lifetime Evolution of Parkinson’s Disease Could Shape Clinical Trial Design: A Shared Patient–Clinician Viewpoint JM Janssen Daalen, A Gerritsen, G Gerritse, J Gouman, H Meijerink, ... Brain Sciences 14 (4), 358, 2024 | | 2024 |
| Model‐Informed Precision Dosing Using Machine Learning for Levothyroxine in General Practice: Development, Validation and Clinical Simulation Trial JM Janssen Daalen, D Doesburg, L Hunik, R Kessel, T Herngreen, ... Clinical Pharmacology & Therapeutics, 2024 | | 2024 |
| Wearables for Parkinson's: Fast-Paced toward Novel Outcome Measures JM Janssen Daalen, TH Oosterhof, BR Bloem, SKL Darweesh Movement disorders: official journal of the Movement Disorder Society, 2023 | | 2023 |
| New-onset gait problems after bilateral STN-DBS for Parkinson’s disease: A systematic review [abstract] JM Janssen Daalen, A Selvaraj, D Georgiev, B Bloem, R Bartels, ... Movement Disorders 37 (Conference abstract), 2022 | | 2022 |
| Cranial swelling in the infant: innocent or neurosurgical emergency? [Dutch] JM Janssen Daalen, E Coolen, JH Schieving Praktische Pediatrie 15 (3), 38-47, 2021 | | 2021 |
| Neurosurgery summer event for students by students: sharing interests JM Janssen Daalen, D Loeffen, J Martens, B Sanaan, DHHM Viering, ... British Journal of Neurosurgery 33 (3), 341-342, 2019 | | 2019 |
| Ex-vivo visualization of the human trigeminal pathways using 11.7 T diffusion MRI and unique microscopy data D Henssen, J Mollink, E Kurt, JM Janssen Daalen, R van Dongen, ... | | 2017 |
Bastiaan R. BloemProfessor of movement disorders neurology, Radboudumc, Nijmegen, the Netherlands在 radboudumc.nl 的电子邮件经过验证
